31843010|t|Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene.
31843010|a|Variations in the POLG1 gene encoding the catalytic subunit of the mitochondrial DNA polymerase gamma, have recently been associated with Parkinson's disease (PD), especially in patients diagnosed with progressive external ophthalmoplegia (PEO). However, the majority of the studies reporting this association mainly focused on the genetic identification of the variation in POLG1 in PD patient primary cells, and determination of mitochondrial DNA copy number, providing little information about the cellular alterations existing in patient brain cells, in particular dopaminergic neurons. Therefore, through the use of induced pluripotent stem cells (iPSCs), we assessed cellular alterations in novel p.Q811R POLG1 (POLG1Q811R) variant midbrain dopaminergic neuron-containing spheroids (MDNS) from a female patient who developed early-onset PD, and compared them to cultures derived from a healthy control of the same gender. Both POLG1 variant and control MDNS contained functional midbrain regionalized TH/FOXA2-positive dopaminergic neurons, capable of releasing dopamine. Western blot analysis identified the presence of high molecular weight oligomeric alpha-synuclein in POLG1Q811R MDNS compared to control cultures. In order to assess POLG1Q811R-related cellular alterations within the MDNS, we applied mass-spectrometry based quantitative proteomic analysis. In total, 6749 proteins were identified, with 61 significantly differentially expressed between POLG1Q811R and control samples. Pro- and anti-inflammatory signaling and pathways involved in energy metabolism were altered. Notably, increased glycolysis in POLG1Q811R MDNS was suggested by the increase in PFKM and LDHA levels and confirmed using functional analysis of glycolytic rate and oxygen consumption levels. Our results validate the use of iPSCs to assess cellular alterations in relation to PD pathogenesis, in a unique PD patient carrying a novel p.Q811R variation in POLG1, and identify several altered pathways that may be relevant to PD pathogenesis.
31843010	108	115	patient	Species	9606
31843010	121	157	progressive external ophthalmoplegia	Disease	MESH:D017246
31843010	162	174	parkinsonism	Disease	MESH:D010302
31843010	206	213	p.Q811R	ProteinMutation	tmVar:p|SUB|Q|811|R;HGVS:p.Q811R;VariantGroup:0;CorrespondingGene:5428;CorrespondingSpecies:9606
31843010	222	227	POLG1	Gene	5428
31843010	252	257	POLG1	Gene	5428
31843010	315	335	DNA polymerase gamma	Gene	5428
31843010	372	391	Parkinson's disease	Disease	MESH:D010300
31843010	393	395	PD	Disease	MESH:D010300
31843010	412	420	patients	Species	9606
31843010	436	472	progressive external ophthalmoplegia	Disease	MESH:D017246
31843010	474	477	PEO	Disease	MESH:D017246
31843010	609	614	POLG1	Gene	5428
31843010	618	620	PD	Disease	MESH:D010300
31843010	621	628	patient	Species	9606
31843010	768	775	patient	Species	9606
31843010	937	944	p.Q811R	ProteinMutation	tmVar:p|SUB|Q|811|R;HGVS:p.Q811R;VariantGroup:0;CorrespondingGene:5428;CorrespondingSpecies:9606
31843010	945	950	POLG1	Gene	5428
31843010	952	957	POLG1	Gene	5428
31843010	957	962	Q811R	ProteinMutation	tmVar:p|SUB|Q|811|R;HGVS:p.Q811R;VariantGroup:0;CorrespondingGene:5428;CorrespondingSpecies:9606
31843010	1043	1050	patient	Species	9606
31843010	1077	1079	PD	Disease	MESH:D010300
31843010	1167	1172	POLG1	Gene	5428
31843010	1244	1249	FOXA2	Gene	3170
31843010	1302	1310	dopamine	Chemical	MESH:D004298
31843010	1394	1409	alpha-synuclein	Gene	6622
31843010	1413	1423	POLG1Q811R	Gene	5428
31843010	1478	1488	POLG1Q811R	Gene	5428
31843010	1699	1709	POLG1Q811R	Gene	5428
31843010	1745	1757	inflammatory	Disease	MESH:D007249
31843010	1858	1868	POLG1Q811R	Gene	5428
31843010	1907	1911	PFKM	Gene	5213
31843010	1916	1920	LDHA	Gene	3939
31843010	1991	1997	oxygen	Chemical	MESH:D010100
31843010	2102	2104	PD	Disease	MESH:D010300
31843010	2131	2133	PD	Disease	MESH:D010300
31843010	2134	2141	patient	Species	9606
31843010	2159	2166	p.Q811R	ProteinMutation	tmVar:p|SUB|Q|811|R;HGVS:p.Q811R;VariantGroup:0;CorrespondingGene:5428;CorrespondingSpecies:9606
31843010	2180	2185	POLG1	Gene	5428
31843010	2249	2251	PD	Disease	MESH:D010300
31843010	Association	MESH:D017246	HGVS:p.Q811R;CorrespondingGene:5428
31843010	Association	MESH:D010300	5428
31843010	Association	MESH:D004298	3170
31843010	Association	MESH:D010302	HGVS:p.Q811R;CorrespondingGene:5428
31843010	Positive_Correlation	MESH:D010300	HGVS:p.Q811R;CorrespondingGene:5428
31843010	Association	5428	6622
31843010	Association	MESH:D010302	5428
31843010	Association	3170	5428
31843010	Association	MESH:D007249	5428
31843010	Association	MESH:D004298	5428
31843010	Association	5213	5428
31843010	Association	3939	5428
31843010	Association	MESH:D017246	5428
31843010	Association	MESH:D017246	5428
31843010	Association	MESH:D010302	5428
31843010	Association	MESH:D010300	5428

